Prostate cancer is a malignancy of one of the major male sex glands, in which cells of the prostate become abnormal and start to grow uncontrollably, forming tumors.
Cutting’ your risk of prostate cancer — Circumcision surgery can lower prostate cancer risk – Circumcision before a male’s first sexual intercourse may help protect against prostate cancer, a new analysis led by researchers at Fred Hutchinson Cancer Research Center has found this new finding to prevent prostate cancer. Circumcision is curative to prostate cancer.
Cancer screening among older adults appears common — What is the Right Cancer Screening Rate for Older Adults? – A high percentage of adults age 75 years and older continue to report receiving cancer screenings, despite U.S. Preventive Services Task Force guidelines recommending against routine screening for breast, cervical, colorectal and prostate cancer for patients age 75 years and older.
Scientists develop vaccine that attacks breast cancer in mice — Implications for the treatment of ovarian, colorectal and pancreatic cancer, as well – Researchers have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer cases-including those that are resistant to common treatments.
FDA: 35 innovative new drugs approved in fiscal year 2011 — Report shows quick approvals of safe and effective medicines occur in the United States before other countries – Over the past 12 months, the U.S. Food and Drug Administration approved 35 new medicines for patients, like two new treatments for hepatitis C; a drug for late-stage prostate cancer; the first new drug for Hodgkin’s lymphoma in 30 years; and the first new drug for lupus in 50 years.
Mayo Clinic study: PSA test valuable in predicting biopsy need, low-risk prostate cancer – The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a Mayo Clinic study has found. The findings were released during a meeting of the North Central Section of the American Urological Association in Rancho Mirage, California, US.
More aggressive treatment not necessary for men with a family history of prostate cancer – Approximately 10-20 percent of prostate cancer patients have a family history of the disease. There are three major factors that are used to evaluate the extent and aggressiveness of prostate cancer, help make treatment decisions, and estimate prognosis: the Prostate Specific Antigen Level (PSA), Gleason score (GS) from the biopsy, and the digital rectal exam findings (DRE).
First Phase III trial of an alpha-pharmaceutical — Shows improved survival in patients with bone metastases and advanced prostate cancer – Until recently, options for patients with bone metastases from advanced prostate cancer have been very limited. But now the first Phase III study of an alpha-pharmaceutical in these patients has shown that it can prolong survival significantly, according to research reported recently at the 2011 European Multidisciplinary Cancer Congress.
Researchers discover 5 inherited genetic variants linked to the most lethal prostate cancers – An international team of researchers led by Fred Hutchinson Cancer Research Center has identified five inherited genetic variants that are strongly associated with aggressive, lethal prostate cancer.
Urine test shows prostate cancer risk, U-M study finds — Test for gene fusion can assist in the early detection of prostate cancer – A new urine test can help aid early detection of and treatment decisions about prostate cancer. Examining the urine sample for TMPRSS2:ERG and PCA3 and stratified patient into low, intermediate and high score, indicating their risk of cancer can help.
Successfully tested in Rwanda, mChip diagnoses infectious diseases like HIV and syphilis at patients’ bedsides; new device could streamline blood testing worldwide – New low-cost diagnostics like the mChip can revolutionize medical care around the world, revealed by researcher in US. Microfluidics-the manipulation of small amounts of fluids-and nanoparticles can be successfully leveraged to produce a functional low-cost diagnostic device in extreme resource-limited settings.
RNZCGP welcomes prostate cancer inquiry results – Encouraging men to seek up-to-date evidenced-based information from their GPs about screening and treatment of prostate cancer disease and screening for prostate cancer is recommended. The Royal New Zealand College of General Practitioners (RNZCGP) has welcomed the release of the results of the Health Select Committee’s inquiry into the early detection and treatment of prostate cancer.
Smoking may increase risk of prostate cancer recurrence, death – Researchers found that men with prostate cancer who were current smokers had a 61% increased risk of dying from prostate cancer, and a 61% higher risk of recurrence compared with men who never smoked. This new study from Harvard School of Public Health (HSPH) and University of California, San Francisco, researchers suggests that men with prostate cancer who smoke increase their risk of prostate cancer recurrence and of dying from the disease.
